13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q3 2019. See the latest, Q2 2026 →

Reported value

$304.85B

−3.2% on the quarter before

Positions

414

40 new · 27 sold out

Top 10

27.3%

of the value

Est. gain

−$6.82B

on stocks held all quarter

Est. return

−2.4%

on those stocks since Q2 2019

Filed

Nov 14, 2019

On SEC EDGAR ↗

Positions as of Sep 30, 2019, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2019. Striped tiles are options.

Meta4.2%Microsoft4.2%
Abbott Laboratories3.1%
Netflix3.1%
Abbvie Inc2.5%
Broadcom2.5%Amazon2.3%
Amgen Inc2.1%
Unitedhealth Group Inc1.6%
Gilead Sciences Inc1.6%
Mastercard1.6%
General Dynamics Corp1.6%
Alibaba1.5%
Exxon Mobil Corp1.4%
Alphabet1.4%
Home Depot Inc1.2%
Eog Resources Inc1.2%
Alphabet1.2%
Csx Corp1.2%
Thermo Fisher Scientific Inc1.1%
Coca-Cola Co1.1%
Intel1.0%
Linde Plc1.0%
Accenture Plc Cl A1.0%

Largest buys

Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Fidelity National Information Svs Inc~$3.04BNew · 0.0% → 1.0%+22,895,290 shares
  2. Netflix~$1.85BAdded · 3.3% → 3.1%+6,921,397 shares
  3. Amgen Inc~$781.2MAdded · 1.7% → 2.1%+4,036,798 shares
  4. Baker Hughes~$669.8MAdded · 0.1% → 0.3%+28,872,582 shares
  5. Carnival Corp Common Paired Stock~$640.4MNew · 0.0% → 0.2%+14,650,486 shares
  6. PSEG~$595.8MAdded · 0.1% → 0.3%+9,597,186 shares
  7. Target Corp~$535.7MNew · 0.0% → 0.2%+5,010,737 shares
  8. L3harris Technologies Inc~$531.0MAdded · 0.3% → 0.5%+2,545,041 shares
  9. Csx Corp~$495.5MAdded · 1.1% → 1.2%+7,152,936 shares
  10. Autodesk~$476.0MAdded · 0.4% → 0.5%+3,222,772 shares

Largest sells

Since Q2 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Worldpay Inc Cl A~$2.91BSold out · 0.9% → 0.0%−23,776,239 shares
  2. Lowes Companies Inc~$2.05BCut · 1.0% → 0.4%−18,632,939 shares
  3. Intel~$1.36BCut · 1.3% → 1.0%−26,456,700 shares
  4. Altria Group Inc~$854.3MCut · 0.9% → 0.5%−20,887,225 shares
  5. Abbvie Inc~$720.0MCut · 2.5% → 2.5%−9,509,347 shares
  6. Marriott International Inc Cl A~$702.0MCut · 1.0% → 0.6%−5,644,284 shares
  7. L3 Technologies Inc~$632.1MSold out · 0.2% → 0.0%−2,578,248 shares
  8. Costco Wholesale Corp~$627.5MCut · 0.8% → 0.8%−2,177,940 shares
  9. Nike Inc Cl B~$564.3MCut · 1.0% → 1.0%−6,008,709 shares
  10. Target Corp~$564.1MSold out · 0.2% → 0.0%−6,512,957 shares

Holdings

As of Sep 30, 2019. Changes are in shares against Jun 30, 2019, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MetaCOMMON STOCK · shares −0.2% · price −7.7%4.2%$12.95B−$1.08B
MicrosoftCOMMON STOCK · shares −1.4% · price +3.8%4.2%$12.92B+$471.0M
Abbott LaboratoriesCOMMON STOCK · shares −3.2% · price −0.5%3.1%$9.46B−$48.6M
NetflixCOMMON STOCK · shares +24% · price −27.1%3.1%$9.44B−$2.83B
Abbvie IncCOMMON STOCK · shares −8.6% · price +4.1%2.5%$7.62B+$301.8M
BroadcomCOMMON STOCK · shares +0.2% · price −4.1%2.5%$7.51B−$319.8M
AmazonCOMMON STOCK · shares −1.5% · price −8.3%2.3%$7.02B−$637.6M
Amgen IncCOMMON STOCK · shares +14% · price +5.0%2.1%$6.50B+$272.8M
Unitedhealth Group IncCOMMON STOCK · shares +2.2% · price −10.9%1.6%$4.91B−$589.7M
Gilead Sciences IncCOMMON STOCK · shares −6.1% · price −6.2%1.6%$4.87B−$321.0M
MastercardCOMMON STOCK · shares +0.8% · price +2.7%1.6%$4.82B+$123.9M
General Dynamics CorpCOMMON STOCK · shares +6.5% · price +0.5%1.6%$4.79B+$22.4M
AlibabaCOMMON STOCK · shares −10% · price −1.3%1.5%$4.56B−$60.5M
Exxon Mobil CorpCOMMON STOCK · shares +0.8% · price −7.9%1.4%$4.36B−$368.4M
AlphabetCOMMON STOCK · shares −3.9% · price +12.8%1.4%$4.19B+$474.6M
Home Depot IncCOMMON STOCK · shares −2.3% · price +11.6%1.2%$3.80B+$394.2M
Eog Resources IncCOMMON STOCK · shares +5.1% · price −20.3%1.2%$3.72B−$904.0M
AlphabetCOMMON STOCK · shares −8.9% · price +12.8%1.2%$3.68B+$416.9M
Csx CorpCOMMON STOCK · shares +16% · price −10.5%1.2%$3.63B−$367.1M
Thermo Fisher Scientific IncCOMMON STOCK · shares −6.4% · price −0.8%1.1%$3.51B−$29.0M
Coca-Cola CoCOMMON STOCK · shares −3.3% · price +6.9%1.1%$3.26B+$210.8M
IntelCOMMON STOCK · shares −30% · price +7.6%1.0%$3.16B+$224.1M
Linde PlcCOMMON STOCK · shares −0.2% · price −3.5%1.0%$3.13B−$114.3M
Accenture Plc Cl ACOMMON STOCK · shares −4.8% · price +4.1%1.0%$3.06B+$120.5M
Fidelity National Information Svs IncCOMMON STOCK · shares New1.00%$3.04B—
Total · 414 positions100%$304.85B−$6.82B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2019 to Q3 2019: 374 stocks held throughout, down $6.82B (−2.4%).

  1. Alphabet+$474.6M+13%
  2. Microsoft+$471.0M+4%
  3. Alphabet+$416.9M+13%
  4. Home Depot Inc+$394.2M+12%
  5. Nike Inc Cl B+$311.4M+12%
  6. Amazon−$637.6M−8%
  7. Concho Resources Inc−$821.6M−34%
  8. Eog Resources Inc−$904.0M−20%
  9. Meta−$1.08B−8%
  10. Netflix−$2.83B−27%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.